JP2013525490A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525490A5
JP2013525490A5 JP2013509201A JP2013509201A JP2013525490A5 JP 2013525490 A5 JP2013525490 A5 JP 2013525490A5 JP 2013509201 A JP2013509201 A JP 2013509201A JP 2013509201 A JP2013509201 A JP 2013509201A JP 2013525490 A5 JP2013525490 A5 JP 2013525490A5
Authority
JP
Japan
Prior art keywords
alkyl
hydroxyl
optionally substituted
halo
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013509201A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/035091 external-priority patent/WO2011140164A1/en
Publication of JP2013525490A publication Critical patent/JP2013525490A/ja
Publication of JP2013525490A5 publication Critical patent/JP2013525490A5/ja
Pending legal-status Critical Current

Links

JP2013509201A 2010-05-06 2011-05-04 Faahのモジュレータとして有用なアザインドール誘導体 Pending JP2013525490A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33197410P 2010-05-06 2010-05-06
US61/331,974 2010-05-06
PCT/US2011/035091 WO2011140164A1 (en) 2010-05-06 2011-05-04 Aza-indole derivatives useful as modulators of faah

Publications (2)

Publication Number Publication Date
JP2013525490A JP2013525490A (ja) 2013-06-20
JP2013525490A5 true JP2013525490A5 (enExample) 2014-06-05

Family

ID=44904047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509201A Pending JP2013525490A (ja) 2010-05-06 2011-05-04 Faahのモジュレータとして有用なアザインドール誘導体

Country Status (8)

Country Link
US (1) US20130059850A1 (enExample)
EP (1) EP2566481A4 (enExample)
JP (1) JP2013525490A (enExample)
CN (1) CN102917707A (enExample)
AU (1) AU2011248175A1 (enExample)
BR (1) BR112012028055A2 (enExample)
CA (1) CA2797281A1 (enExample)
WO (1) WO2011140164A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201411236D0 (en) * 2014-06-25 2014-08-06 Takeda Pharmaceutical Novel compounds
DK3362449T3 (da) * 2015-10-13 2021-07-19 Inst Nat Sante Rech Med Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose
CN110352192B (zh) * 2016-09-16 2023-03-24 住友化学株式会社 杂环化合物及含有其的有害节肢动物防治剂
CN109589325B (zh) * 2019-02-19 2019-11-26 牡丹江医学院 一种用于治疗肠炎的药物组合物及其制备方法
US12358875B2 (en) * 2019-06-17 2025-07-15 Ucb Pharma Gmbh N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as GPR17 modulators for treating CNS disorders such as multiple sclerosis
CN111743864B (zh) * 2020-08-05 2022-04-01 牡丹江医学院 一种体育外伤喷雾剂及其制备方法
CN112159423A (zh) * 2020-11-03 2021-01-01 凯美克(上海)医药科技有限公司 1H-吡咯并[2,3-b]吡啶-2-硼酸频哪醇酯的合成方法
JP2024506530A (ja) * 2021-01-25 2024-02-14 シービーライフ フェロトーシス制御性細胞死の阻害剤としてのインドール、6-および7-アザインドール誘導体の使用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH574441A5 (enExample) * 1973-06-14 1976-04-15 Ciba Geigy Ag
JPS5239672A (en) * 1975-09-26 1977-03-28 Sankyo Co Ltd Process for preparing indole-2-allyl-3- thioeter compounds
IL84796A (en) * 1986-12-17 1992-03-29 Merck Frosst Canada Inc Substituted n-benzyl-indoles and pharmaceutical compositions containing them
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
BR9405737A (pt) * 1993-02-24 1995-12-05 Merck & Co Inc Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC
FR2705346B1 (fr) * 1993-05-18 1995-08-11 Union Pharma Scient Appl Nouveaux dérivés de pipéridinyl thio indole, leurs procédés de préparation, compositions pharmaceutiques les contenant, utiles notamment comme antalgiques .
BR0307406A (pt) * 2002-02-01 2004-12-28 Hoffmann La Roche Indóis substituìdos como agonistas alfa-1
UA78999C2 (en) * 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
TW200403243A (en) * 2002-07-18 2004-03-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
AU2004213375A1 (en) * 2003-02-14 2004-09-02 Wyeth Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-Hydroxytryptamine-6 ligands
US7361763B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
SI1791537T1 (sl) * 2004-08-19 2010-02-26 Aventis Pharma Inc 3-ariltioindol-2-karboksamidni derivati in njihovi analogi kot inhibitorji kazein-kinaze I
GB2422831A (en) * 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
PL2395004T3 (pl) * 2005-06-22 2016-08-31 Plexxikon Inc Pochodne pirolo[2,3-b]pirydyny jako inhibitory kinazy białkowej
EP1998766A2 (en) * 2005-12-16 2008-12-10 Ironwood Pharmaceuticals, Inc. Useful indole compounds
TW201242961A (en) * 2007-06-20 2012-11-01 Ironwood Pharmaceuticals Inc FAAH inhibitors
MX2010009203A (es) * 2008-02-22 2010-11-10 Irm Llc Compuestos y composiciones como modulares de la actividad de gpr119.
PT2276732E (pt) * 2008-04-16 2015-09-28 Karobio Ab Novos ligandos do recetor de estrogénio

Similar Documents

Publication Publication Date Title
JP2013525490A5 (enExample)
JP2013525356A5 (enExample)
JP2011509309A5 (enExample)
JP2006502143A5 (enExample)
JP2015505296A5 (enExample)
JP2013520502A5 (enExample)
JP2009542613A5 (enExample)
JP2013523814A5 (enExample)
JP2014051526A5 (enExample)
JP2012041365A5 (enExample)
JP2014511892A5 (enExample)
JP2014508811A5 (enExample)
JP2013510120A5 (enExample)
JP2014507455A5 (enExample)
JP2014513110A5 (enExample)
JP2013542261A5 (enExample)
JP2013505969A5 (enExample)
JP2016506962A5 (enExample)
JP2013525458A5 (enExample)
JP2014509647A5 (enExample)
JP2013529196A5 (enExample)
JP2017517538A5 (enExample)
JP2016525135A5 (enExample)
JP2016040288A5 (enExample)
JP2013544846A5 (enExample)